Host cellular signaling induced by influenza virus

Science China Life Sciences

Volumn 54, Issue 1, 2011, Pages 68-74

  Dai, Xin Xian ^a   Zhang, Li Shu ^a   Hong, Tao ^b  

^a BEIJING JIAOTONG UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

influenza virus; signal transduction; virus host interaction

Indexed keywords

ORTHOMYXOVIRIDAE;

EID: 78751651077     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-4116-z     Document Type: Review

References (105)

1. Proud C G. PKR: A new name and new roles. Trends Biochem Sci, 1995, 20: 241-246.
2. Williams B R. PKR; a sentinel kinase for cellular stress. Oncogene, 1999, 18: 6112-6120.
3. Dauber B, Martinez-Sobrido L, Schneider J, et al. Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog, 2009, 5: e1000473.
4. Balachandran S, Barber G N. PKR in innate immunity, cancer, and viral oncolysis. Methods Mol Biol, 2007, 383: 277-301.
5. Garcia M A, Meurs E F, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie, 2007, 89: 799-811.
6. Balachandran S, Roberts P C, Brown L E, et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity, 2000, 13: 129-141.
7. Takizawa T, Ohashi K, Nakanishi Y. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol, 1996, 70: 8128-8132.
8. Balachandran S, Roberts P C, Kipperman T, et al. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol, 2000, 74: 1513-1523.
9. Li S, Min J Y, Krug R M, et al. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology, 2006, 349: 13-21.
10. Lu Y, Wambach M, Katze M G, et al. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology, 1995, 214: 222-228.
11. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol, 2003, 21: 335-376.
12. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol, 2004, 4: 499-511.
13. Diebold S S, Kaisho T, Hemmi H, et al. Innate Antiviral responses by means of TLR7-Mediated recognition of single-stranded RNA. Science, 2004, 303: 1529-1531.
14. Lund J M, Alexopoulou L, Sato A, et al. Recognition of sin gle-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA, 2004, 101: 5598-5603.
15. Guillot L, Le Goffic R, Bloch S, et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem, 2005, 280: 5571-5580.
16. Lee D C, Cheung C Y, Law A H, et al. p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J Virol, 2005, 79: 10147-10154.
17. Maruoka S, Hashimoto S, Gon Y, et al. ASK1 regulates influenza virus infection-induced apoptotic cell death. Biochem Biophys Res Commun, 2003, 307: 870-876.
18. Kujime K, Hashimoto S, Gon Y, et al. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J Immunol, 2000, 164: 3222-3228.
19. Ludwig S, Ehrhardt C, Neumeier E R, et al. Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem, 2001, 276: 10990-10998.
20. Kakugawa S, Shimojima M, Goto H, et al. The MAPK-activated kinase RSK2 plays a role in innate immune responses to influenza virus infection. J Virol, 2009.
21. Kajiya T, Orihara K, Hamasaki S, et al. Toll-like receptor 2 expression level on monocytes in patients with viral infections: Monitoring infection severity. J Infect, 2008, 57: 249-259.
22. Lee R M, White M R, Hartshorn K L. Influenza a viruses upregulate neutrophil toll-like receptor 2 expression and function. Scand J Immunol, 2006, 63: 81-89.
23. Whitmore M M, Iparraguirre A, Kubelka L, et al. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol, 2007, 179: 3622-3630.
24. Barral P M, Sarkar D, Su Z-z, et al. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity. Pharmacol Ther, 2009, 124: 219-234.
25. Yoneyama M, Fujita T. RIG-I family RNA helicases: Cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev, 2007, 18: 545-551.
26. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol, 2008, 20: 17-22.
27. Le Goffic R, Pothlichet J, Vitour D, et al. Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol, 2007, 178: 3368-3372.
28. Siren J, Imaizumi T, Sarkar D, et al. Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect, 2006, 8: 2013-2020.
29. Matikainen S, Siren J, Tissari J, et al. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol, 2006, 80: 3515-3522.
30. Hale B G, Randall R E, Ortin J, et al. The multifunctional NS1 protein of influenza A viruses. J Gen Virol, 2008, 89: 2359-2376.
31. Talon J, Horvath C M, Polley R, et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol, 2000, 74: 7989-7996.
32. Ehrhardt C, Seyer R, Hrincius E R, et al. Interplay between influenza A virus and the innate immune signaling. Microbes Infect, 2010, 12: 81-87.
33. Guo Z, Chen L M, Zeng H, et al. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol, 2007, 36: 263-269.
34. Mibayashi M, Martinez-Sobrido L, Loo Y M, et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol, 2007, 81: 514-524.
35. Opitz B, Rejaibi A, Dauber B, et al. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol, 2007, 9: 930-938.
36. Gack M U, Albrecht R A, Urano T, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe, 2009, 5: 439-449.
37. Nemeroff M E, Barabino S M L, Li Y, et al. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs. Mol Cell, 1998, 1: 991-1000.
38. Conenello G M, Palese P. Influenza A virus PB1-F2: A small protein with a big punch. Cell Host Microbe, 2007, 2: 207-209.
39. Mitzner D, Dudek S E, Studtrucker N, et al. Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol, 2009, 11: 1502-1516.
40. Zamarin D, Garcia-Sastre A, Xiao X, et al. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog, 2005, 1: e4.
41. McAuley J L, Hornung F, Boyd K L, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe, 2007, 2: 240-249.
42. Zamarin D, Ortigoza M B, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol, 2006, 80: 7976-7983.
43. Mazur I, Wurzer W J, Ehrhardt C, et al. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kB-inhibiting activity. Cell Microbiol, 2007, 9: 1683-1694.
44. Toker A. Signaling through protein kinase C. Front Biosci, 1998, 3: D1134-1147.
45. Hoffmann H H, Palese P, Shaw M L. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res, 2008, 80: 124-134.
46. + channels in respiratory epithelia. Proc Natl Acad Sci USA, 2000, 97: 10282-10287.
47. Lazrak A, Iles K E, Liu G, et al. Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species. FASEB J, 2009, 23: 3829-3842.
48. Sieczkarski S B, Whittaker G R. Characterization of the host cell entry of filamentous influenza virus. Arch Virol, 2005, 150: 1783-1796.
49. Constantinescu S N, Cernescu C D, Popescu L M. Effects of protein kinase C inhibitors on viral entry and infectivity. FEBS Lett, 1991, 292: 31-33.
50. Arora D J, Gasse N. Influenza virus hemagglutinin stimulates the protein kinase C activity of human polymorphonuclear leucocytes. Arch Virol, 1998, 143: 2029-2037.
51. Root C N, Wills E G, McNair L L, et al. Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor. J Gen Virol, 2000, 81: 2697-2705.
52. Sieczkarski S B, Brown H A, Whittaker G R. Role of protein kinase C betaII in influenza virus entry via late endosomes. J Virol, 2003, 77: 460-469.
53. Pleschka S. RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade. Biol Chem, 2008, 389: 1273-1282.
54. Huang X, Liu T, Muller J, et al. Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export. Virology, 2001, 287: 405-416.
55. Sakaguchi A, Hirayama E, Hiraki A, et al. Nuclear export of influenza viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral matrix protein. Virology, 2003, 306: 244-253.
56. Ludwig S, Wolff T, Ehrhardt C, et al. MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Letters, 2004, 561: 37-43.
57. Pleschka S, Wolff T, Ehrhardt C, et al. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol, 2001, 3: 301-305.
58. Marjuki H, Alam M I, Ehrhardt C, et al. Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling. J Biol Chem, 2006, 281: 16707-16715.
59. Marjuki H, Yen H L, Franks J, et al. Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. Virol J, 2007, 4: 134.
60. Beaton A R, Krug R M. Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo. Nucleic Acids Res, 1981, 9: 4423-4436.
61. Krug R M. Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr Top Microbiol Immunol, 1981, 93: 125-149.
62. Chen Z, Li Y, Krug R M. Influenza A virus NS1 protein targetspoly(A)-binding protein II of the cellular 3[prime]-end processing machinery. EMBO J, 1999, 18: 2273-2283.
63. Lu Y, Qian X Y, Krug R M. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev, 1994, 8: 1817-1828.
64. Garfinkel M S, Katze M G. Translational control by influenza virus. Selective translation is mediated by sequences within the viral mRNA 5′-untranslated region. J Biol Chem, 1993, 268: 22223-22226.
65. de la Luna S, Fortes P, Beloso A, et al. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol, 1995, 69: 2427-2433.
66. Enami K, Sato T A, Nakada S, et al. Influenza virus NS1 protein stimulates translation of the M1 protein. J Virol, 1994, 68: 1432-1437.
67. Katze M G, DeCorato D, Krug R M. Cellular mRNA translation is blocked at both initiation and elongation after infection by influenza virus or adenovirus. J Virol, 1986, 60: 1027-1039.
68. Park Y W, Katze M G. Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J Biol Chem, 1995, 270: 28433-28439.
69. Aragon T, de la Luna S, Novoa I, et al. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol, 2000, 20: 6259-6268.
70. Burgui I, Aragon T, Ortin J, et al. PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol, 2003, 84: 3263-3274.
71. Feigenblum D, Schneider R J. Modification of eukaryotic initiation factor 4F during infection by influenza virus. J Virol, 1993, 67: 3027-3035.
72. Katze M G. Regulation of the interferon-induced PKR: can viruses cope? Trends in Microbiology, 1995, 3: 75-78.
73. Goodman A G, Smith J A, Balachandran S, et al. The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-Mediated mechanism. J Virol, 2007, 81: 2221-2230.
74. Hatada E, Hasegawa M, Mukaigawa J, et al. Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J Biochem, 1989, 105: 537-546.
75. Shapiro G I, Gurney T, Jr Krug R M. Influenza virus gene expression: control mechanisms at early and late times of infection and nuclearcytoplasmic transport of virus-specific RNAs. J Virol, 1987, 61: 764-773.
76. Yamanaka K, Nagata K, Ishihama A. Temporal control for translation of influenza virus mRNAs. Arch Virol, 1991, 120: 33-42.
77. Duronio V. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J, 2008, 415: 333-344.
78. Franke T F, Hornik C P, Segev L, et al. PI3K/Akt and apoptosis: size matters. Oncogene, 2003, 22: 8983-8998.
79. Ji W T, Liu H J. PI3K-Akt signaling and viral infection. Recent Pat Biotechnol, 2008, 2: 218-226.
80. Hale B G, Batty I H, Downes C P, et al. Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem, 2008, 283: 1372-1380.
81. Hale B G, Jackson D, Chen Y H, et al. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA, 2006, 103: 14194-14199.
82. Hale B G, Randall R E. PI3K signalling during influenza A virus infections. Biochem Soc Trans, 2007, 35: 186-187.
83. Shin Y K, Li Y, Liu Q, et al. SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol, 2007, 81: 12730-12739.
84. Shin Y K, Liu Q, Tikoo S K, et al. Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol, 2007, 88: 13-18.
85. Ehrhardt C, Wolff T, Pleschka S, et al. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol, 2007, 81: 3058-3067.
86. Zhirnov O P, Klenk H D. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis, 2007, 12: 1419-1432.
87. Lu X Y, Masic A, Li Y, et al. The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1. J Gen Virol, 2010, 91: 1439-1449.
88. Ehrhardt C, Ludwig S. A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell Microbiol, 2009, 11: 863-871.
89. Ehrhardt C, Marjuki H, Wolff T, et al. Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol, 2006, 8: 1336-1348.
90. Shin Y K, Liu Q, Tikoo S K, et al. Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J Gen Virol, 2007, 88: 942-950.
91. Flory E, Kunz M, Scheller C, et al. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem, 2000, 275: 8307-8314.
92. Tenoever B R, Ng S L, Chua M A, et al. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science, 2007, 315: 1274-1278.
93. Pahl H L, Baeuerle P A. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J Virol, 1995, 69: 1480-1484.
94. Gern J E, French D A, Grindle K A, et al. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol, 2003, 28: 731-737.
95. Severa M, Fitzgerald K A. TLR-mediated activation of type I IFN during antiviral immune responses: fighting the battle to win the war. Curr Top Microbiol Immunol, 2007, 316: 167-192.
96. Nimmerjahn F, Dudziak D, Dirmeier U, et al. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol, 2004, 85: 2347-2356.
97. Kumar N, Xin Z T, Liang Y, et al. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol, 2008, 82: 9880-9889.
98. Wurzer W J, Ehrhardt C, Pleschka S, et al. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem, 2004, 279: 30931-30937.
99. Berghall H, Siren J, Sarkar D, et al. The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines. Microbes Infection, 2006, 8: 2138-2144.
100. Liu P, Jamaluddin M, Li K, et al. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol, 2007, 81: 1401-1411.
101. Thompson A J, Locarnini S A. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol, 2007, 85: 435-445.
102. Pothlichet J, Chignard M, Si-Tahar M. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol, 2008, 180: 2034-2038.
103. Rintahaka J, Wiik D, Kovanen P E, et al. Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3. J Immunol, 2008, 180: 1749-1757.
104. Karlas A, Machuy N, Shin Y, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature, 2010, 463: 818-822.
105. Konig R, Stertz S, Zhou Y, et al. Human host factors required for influenza virus replication. Nature, 2010, 463: 813-817.